動物用ワクチン市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00003539
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 181
Buy Now

動物用ワクチン市場は、2021年の99億8,465万米ドルから2028年までに155億3,638万米ドルに達すると予測されています。 2021 年から 2028 年までに 6.5% の CAGR が記録されると推定されています。



動物用ワクチンは、さまざまな病原体によって引き起こされる感染症を予防するために使用される非経口製品です。これらのワクチンは、生命を脅かすさまざまな病気から動物を守ります。動物用ワクチンは、ペットや家畜の長寿、健康、そして全体的な生産を費用対効果の高い方法で確保する上で重要な役割を果たします。動物用ワクチンは、不活化ワクチン、弱毒化生ワクチン、トキソイドワクチン、および組換えワクチンに分類されます。市場の成長を促進する主な要因は、人獣共通感染症の発生率の増加と、食中毒と感染症の有病率の上昇です。しかし、動物用ワクチンの使用に関する政府の厳格な規則が市場の成長を妨げています。動物用ワクチン市場は地域ごとに、北米、ヨーロッパ、アジア太平洋(APAC)、中東およびアフリカ(MEA)、南中米(SAM)に分割されています。北米は、愛玩動物の導入の増加、肉と牛乳の消費量の増加、動物の予防接種の利点に対する理解の高まりにより、世界市場を支配しています。



戦略的洞察



動物用ワクチン市場



市場洞察



人獣共通感染症の発生率の増加



動物は有害な細菌、ウイルス、寄生虫、真菌を人に運び、病気を引き起こします。このような病気は人獣共通感染症または人獣共通感染症として知られています。人獣共通感染症の臨床影響は軽度から重度まで多岐にわたり、場合によっては死に至る場合もあります。人獣共通感染症は世界中に蔓延しています。アメリカ疾病予防管理センター(CDC)の予測によると、人間の既存の感染症の 10 件中 6 件以上は動物を介して広がる可能性があり、新規または将来の人間の感染症の 4 件中 3 件は動物に由来するとされています。さらに、2016 年には、アジアとアフリカで少なくとも 55,000 人が狂犬病で死亡しました。



過去数十年の間に、エボラウイルス、西ナイルウイルス、ヒト免疫不全ウイルスなどのウイルスを引き起こすいくつかの新しい感染性ヒト疾患が発生しました。 HIV、ニパウイルス、ハンタウイルス感染症は、動物の保有源から進化しました。重症急性呼吸器症候群(SARS)や鳥インフルエンザなどの流行は、動物の宿主からの細菌が人間の宿主に適応する可能性を強調しています。 21 世紀初頭に新規、新興、または再興しているヒトの病気の 4 分の 3 以上は、動物または動物由来の製品に由来する病原体によって引き起こされています。 WHO によると、世界中で確認されている新たな感染症の約 60% が人獣共通感染症であり、毎年 10 億人以上が人獣共通感染症により発症し、数百万人が死亡しています。過去 30 年間で 30 件以上の新規ヒト感染症が発見されており、そのうち 75% は動物由来です。したがって、新興および再興の人獣共通感染症により、動物の健康への需要が高まっています。したがって、企業は、動物の飼い主やその他の関係者が動物の全体的な健康を維持できるように、改良された医薬品やワクチンを生産しています。したがって、人獣共通感染症の発生率の増加は、動物用ワクチン市場の成長を促進します。



ワクチンの種類に基づく洞察



世界の動物用ワクチン市場は、ワクチンの種類に基づいて次のように分類されます。家畜ワクチン、愛玩動物ワクチンなど。家畜ワクチンセグメントは、2021年に最大の市場シェアを保持する可能性が高い。ただし、コンパニオンアニマルセグメントは、予測期間中に7.0%という最高のCAGRを記録すると予想される。



ワクチンの種類別動物ワクチン市場- 2021 年と 2028 年





テクノロジーベースの洞察



世界の動物用ワクチン市場は、テクノロジーに基づいて弱毒化生ワクチン、不活化ワクチン、トキソイドに分類されます。ワクチン、組換えワクチン、複合ワクチンなど。 2021年には、弱毒化生ワクチン部門が最大の市場シェアを保持するとみられる。ただし、不活化ワクチンセグメントは、2021 年から 2028 年にかけて最も高い CAGR で成長すると予想されています。



動物用ワクチン市場のプレーヤーは、製品の発売や拡大などの有機的な戦略を採用し、世界中でその拠点と製品ポートフォリオを拡大しています。



地理



地理的に、動物用ワクチン市場は北米 (米国、カナダ、メキシコ)、欧州 (フランス、ドイツ、英国、スペイン、イタリア、その他のヨーロッパ)、アジア太平洋(中国、インド、日本、オーストラリア、韓国、その他のアジア太平洋地域)、中東およびアフリカ(サウジアラビア、UAE、南アフリカ、



新型コロナウイルスの影響



ヨーロッパ諸国は、新型コロナウイルスの影響により大きな影響を受けています-19パンデミック。ウイルスの発生を制御するために、政府によってさまざまな制限が課されました。これにより、あらゆる業界の各分野で破壊、限界、課題、変化が生じました。同様に、動物ワクチン業界もパンデミックの影響を受けました。例えば、海外の獣医団体は、動物患者のケアを急性疾患の動物や緊急事態に限定することを推奨しています。さらに、ロックダウンにより、年次健康診断検査や選択的ワクチン接種手順の再スケジュールが発生しました。



しかし、世界中の政府機関がワクチン接種を維持するために厳格な措置を講じているため、さまざまな主要企業が動物ワクチンの供給を確保しています。人獣共通感染症ウイルスが地域社会に広がるのを防ぐために供給します。しかし、新型コロナウイルス感染症が動物ワクチン市場に及ぼす全体的な影響は、獣医の診察が制限され、動物医療のアプローチが緊急症例や重症動物へのケアの提供に変更されたことによる需要の減少により、依然としてかなりマイナスの影響を及ぼしています。



会社概要





  • ベーリンガーインゲルハイム インターナショナル GmbH

  • MERCK

  • Zoetis Services LLC

  • Elanco

  • < li>ベトキノール
  • Ceva

  • ビルバック

  • NEOGEN Corporation

  • バイオバック

  • ImmuCell Corporation

  • < /ul>
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Veterinary Vaccines?

A Veterinary Vaccines is a sterile glass or plastic test tube with a stopper that creates a vacuum inside the tube so that a preset volume of liquid can be depicted. The Veterinary Vaccines prevents needle stick damage by preventing needles from coming in human contact and thus, adulteration. A double-pointed needle is fitted to a plastic tubular adapter in the vacuum blood collecting tube. Double pointed needles are available in numerous gauge sizes. The needle's length varies from 1 to 1 1/2 inches. Additional elements may be present in Veterinary Vacciness, which are used to preserve blood for treatment in a medical laboratory.

What are the driving factors for the Veterinary Vaccines market across the globe?

Key factors that are driving growth of the market are increasing incidence of zoonotic diseases and rising prevalence foodborne diseases and infections propel the market growth. However, strict government rules related to the usage of veterinary vaccines hamper the growth of the market.

What will be the CAGR of Veterinary Vaccines market?

The Veterinary Vaccines market is anticipated to grow around 6.5% CAGR amid the forecast period 2021-2028.

Who are the key players in the Veterinary Vaccines market?

Boehringer Ingelheim International GmbH and Zoetis Inc., are the key players in the Veterinary Vaccines market.

Which segment among Veterinary Vaccines market provides the most opportunity for growth?

Livestock vaccines segment market provides the most opportunity for growth.

The List of Companies - Veterinary Vaccines Market

  1. Boehringer Ingelheim International GmbH
  2. MERCK
  3. Zoetis Services LLC
  4. Elanco
  5. Vetoquinol
  6. Ceva
  7. Virbac
  8. NEOGEN Corporation
  9. Biovac
  10. ImmuCell Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports